Business
Press Release Aug 13 2024
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 13, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Dabigatran Etexilate Capsules, 110 mg".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 13, 2024, titled \"Alembic Pharmaceuticals receives USFDA Final Approval for Dabigatran Etexilate Capsules, 110 mg\". View Attachment","length":397,"tagName":"div"}]